Benlysta

GSK receives orphan drug designation for Benlysta to treat systemic sclerosis
Pharmaceutical Business Review
Thu, 02/2/23 - 10:25 am
GSK
FDA
orphan drugs
Benlysta
systemic sclerosis
GSK survey finds COVID, lack of early HCP conversations hitting lupus patients' care
Fierce Pharma
Tue, 11/29/22 - 08:29 pm
GSK
lupus
Benlysta
patients
COVID-19
pharma marketing
AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class lupus drug Saphnelo
Fierce Pharma
Mon, 08/2/21 - 11:08 am
AstraZeneca
GSK
FDA
lupus
Saphnelo
systemic lupus erythematosus
Benlysta
GlaxoSmithKline debuts DTC campaign for lupus med Benlysta as it looks to cement category lead
Fierce Pharma
Tue, 07/27/21 - 04:24 pm
GSK
lupus
Benlysta
DTC advertising
As GSK, Aurinia heat up the lupus nephritis category, analyst gauges doctors' first impressions
Fierce Pharma
Thu, 06/24/21 - 11:11 am
GSK
Aurinia
lupus nephritis
Benlysta
Lupkynis
FDA
After losing race for first to market in lupus nephritis, Aurinia taps Otsuka for voclosporin licensing pact abroad
Endpoints
Thu, 12/17/20 - 06:18 pm
Aurinia Pharmaceuticals
lupus nephritis
GSK
Otsuka
Benlysta
AstraZeneca lupus drug shows potential, but it may not be enough for FDA
Biopharma Dive
Thu, 12/19/19 - 01:05 pm
AstraZeneca
lupus
anifrolumab
GSK
Benlysta
GlaxoSmithKline's Benlysta eyes lupus sales boost after kidney trial win
Fierce Pharma
Wed, 12/18/19 - 10:54 am
GSK
Benlysta
lupus
GSK gets FDA nod for Benlysta to treat pediatric patients with lupus
Pharmaceutical Business Review
Mon, 04/29/19 - 09:37 am
GSK
FDA
Benlysta
SLE
systemic lupus erythematosus
pediatrics
GSK trials Benlysta/rituximab combo for lupus
Pharma Times
Thu, 03/22/18 - 10:31 pm
GSK
clinical trials
Benlysta
rituximab
lupus
GSK gets go-ahead for new Benlysta formulation
BioPharma Dive
Wed, 07/26/17 - 10:20 pm
GSK
Benlysta
systemic lupus erythematosus
SLE
Samsung Bioepis launches a Remicade knockoff at a 35% discount; FDA OK’s a self-administered version of Benlysta
Endpoints
Mon, 07/24/17 - 10:40 am
Samsung Bioepis
Remicade
FDA
biosimilars
JNJ
GSK
Benlysta
lupus
5 Biotech Stocks With Major Catalysts in July
Motley Fool
Wed, 06/28/17 - 11:03 pm
biotech
AcelRx
Zalviso
Alnylam
Patisiran
Dynavax
HEPLISAV-B
GSK
Benlysta
Puma Biotechnology
neratinib
Benlysta maker GSK drafts soccer star Boxx to get lupus patients talking
Fierce Pharma
Mon, 04/17/17 - 11:11 am
Benlysta
GSK
lupus
patients
GSK's lupus drug finally wins NICE backing, but only after discounts
BioPharma Dive
Thu, 05/12/16 - 09:40 am
GSK
lupus
NICE
UK
Benlysta
AstraZeneca, GlaxoSmithKline stake rival claims on new lupus therapies
Fierce Biotech
Wed, 11/11/15 - 09:56 am
AstraZeneca
GSK
lupus
Benlysta
MEDI-546
AstraZeneca lupus drug produces positive results in trial
Yahoo/Reuters
Mon, 11/17/14 - 08:31 am
AstraZeneca
lupus
Benlysta
sifalimumab
GlaxoSmithKline Launches Phase 3 Trial for Benlysta
Motley Fool
Fri, 04/5/13 - 10:19 am
GSK
Benlysta
ANCA-positive vasculitis
10 top drug launch disasters
Fierce Pharma
Wed, 11/28/12 - 11:13 am
drug launches
Rare Disease Therapeutics
Anascorp
AstraZeneca
Brilinta
Somaxon
Silenor
Sanofi
Multaq
Savient
Krystexxa
XenoPort
Horizant
Human Genome Sciences
Benlysta
Zaltrap
Dendreon
Provenge
KV Pharmaceutical
Makena
Biogen Sells Benlysta Rights
Yahoo/Zacks
Fri, 09/14/12 - 11:51 am
Biogen
Benlysta
GSK

Pages